Comparing laparoscopic and robotic surgery for kidney tumors
Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.
This study is testing whether laparoscopic or robotic surgery works better for people with small kidney tumors to see which method leads to fewer complications and faster recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Menoufia University Academic / other |
| Locations | 1 site (Shibīn al Kawm, Menoufia -) |
| Trial ID | NCT06424080 on ClinicalTrials.gov |
What this trial studies
This study evaluates the oncological and perioperative outcomes of laparoscopic versus robotic partial nephrectomy in patients with renal cell carcinoma. It aims to determine which surgical approach offers better results in terms of complications, blood loss, and recovery time. The study focuses on patients with T1 renal tumors who are candidates for partial nephrectomy, utilizing modern minimally invasive techniques. By comparing these two methods, the research seeks to provide insights into the most effective surgical options for treating localized kidney cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with T1 renal tumors that are suitable for partial nephrectomy.
Not a fit: Patients who are unfit for partial nephrectomy, have tumors larger than 7cm, or have metastatic or locally advanced disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify the optimal surgical approach for patients with renal tumors, potentially leading to improved recovery and outcomes.
How similar studies have performed: Previous studies have shown promising results with both laparoscopic and robotic approaches in similar surgical contexts, indicating that this comparison is relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * renal mass T1 according to TNM amenable for partial nephrectomy. Exclusion Criteria: * any unfit pt for partial nephrectomy * more than 7cm tumor * mass not amenable for partial nephrectomy * metastatic tumor or locally advanced
Where this trial is running
Shibīn al Kawm, Menoufia -
- Hossam Kandeel — Shibīn al Kawm, Menoufia -, Egypt (Recruiting)
Study contacts
- Study coordinator: hossam elsayed kandeel, MSC
- Email: hossamkandeel016@gmail.com
- Phone: 01097991198
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.